Citation Tools
Section 5: Patient safety and quality assurance
5PSQ-177 Cardiovascular risk and altered lipid profile associated with treatment with the kinase JAK inhibitors, tofacitinib and baricitinib
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 5PSQ-177 Cardiovascular risk and altered lipid profile associated with treatment with the kinase JAK inhibitors, tofacitinib and baricitinib